arrow
C

Cristiano de Pádua Souza

hospital de câncer de barretos
H指数:16
被引数:995

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pre-Analytical and Analytical Challenges in Whole-Exome Sequencing of Formalin-Fixed Paraffin-Embedded Breast and Prostate Cancer Tissue: A Real-World Multicenter Study

甲醛固定石蜡包埋乳腺癌和前列腺癌组织全外显子测序的预分析及分析挑战:一项真实世界多中心研究

2026-05-230
OA
Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer

公共与私人保险覆盖对早期雌激素受体阳性乳腺癌女性生活质量的影响

2025-12-050
OAAI
Employment Status Among Brazilian Women With Estrogen Receptor-Positive Nonmetastatic Breast Cancer

巴西雌激素受体阳性非转移性乳腺癌女性患者的就业状况

2025-10-290
OAAI
Non-metastatic breast cancer in older patients in Brazil: Adherence to endocrine therapy, quality of life, and sexual health

巴西老年非转移性乳腺癌患者:内分泌治疗的依从性、生活质量及性健康

2025-09-120
PRE
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study

真实世界中接受辅助紫杉醇联合曲妥珠单抗(APT)方案治疗的I期HER2阳性早期乳腺癌患者的5年结果:一项国际回顾性研究

2025-05-150
PRE
Analysis of cytokines, chemokines, and tumor-infiltrating lymphocytes as immunological markers predicting pathological complete response in triple-negative breast cancer: Exploratory analysis of the NACATRINE trial

细胞因子、趋化因子和肿瘤浸润淋巴细胞作为预测三阴性乳腺癌病理完全缓解的免疫学标志物的分析:NACATRINE试验的探索性分析

2024-09-010
PRE
Adherence to endocrine therapy and sexual dysfunction in patients older than 65 years with early estrogen receptor-positive breast cancer

内分泌治疗的依从性及≥65岁早期雌激素受体阳性乳腺癌患者的性功能障碍

2024-09-010
PRE
Cancer health disparities among patients with early-stage estrogen receptorpositive (ER plus ) breast cancer treated in public or private practices in Brazil
2024-05-020
PRE
ANNE: A phase II single-arm clinical trial to assess the feasibility and efficacy of neoadjuvant anastrozole in patients with luminal breast cancer and low proliferative index in TNM stages II and III
2024-05-020
PRE
Return to work in Brazilian women on adjuvant endocrine therapy
2024-05-020
PRE
Suboptimal adherence to adjuvant endocrine therapy (ET) in Brazilian women with early-stage estrogen receptor-positive (ER plus ) breast cancer
2024-05-021
PRE